These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35606187)

  • 1. Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders.
    Endres D; von Zedtwitz K; Matteit I; Bünger I; Foverskov-Rasmussen H; Runge K; Feige B; Schlump A; Maier S; Nickel K; Berger B; Schiele MA; Cunningham JL; Domschke K; Prüss H; Tebartz van Elst L
    Biol Psychiatry; 2022 Aug; 92(4):261-274. PubMed ID: 35606187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational study on the association of anti-thyroid autoantibodies with clinical, EEG, MRI, FDG-PET, cerebrospinal fluid and anti-neuronal antibody findings in 530 patients with schizophreniform and affective disorders.
    Endres D; Runge K; Meixensberger S; Feige B; Denzel D; Pankratz B; Maier S; Nickel K; Michel M; Venhoff N; Schiele MA; Domschke K; Prüss H; Tebartz van Elst L
    Psychoneuroendocrinology; 2021 Sep; 131():105320. PubMed ID: 34171794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis.
    Endres D; Meixensberger S; Dersch R; Feige B; Stich O; Venhoff N; Matysik M; Maier SJ; Michel M; Runge K; Nickel K; Urbach H; Domschke K; Prüss H; Tebartz van Elst L
    Transl Psychiatry; 2020 Aug; 10(1):279. PubMed ID: 32782247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-astrocytic autoantibody patterns in the cerebrospinal fluid of patients with depression and psychosis.
    Endres D; Lerchenmüller V; Runge K; von Zedtwitz K; Nickel K; Urbach H; Domschke K; Prüss H; Tebartz van Elst L
    Psychiatry Res; 2022 Nov; 317():114905. PubMed ID: 36265195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
    Franke C; Boesl F; Goereci Y; Gerhard A; Schweitzer F; Schroeder M; Foverskov-Rasmussen H; Heine J; Quitschau A; Kandil FI; Schild AK; Finke C; Audebert HJ; Endres M; Warnke C; Prüss H
    Brain Behav Immun; 2023 Mar; 109():139-143. PubMed ID: 36657623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune Psychosis.
    Endres D; Rauer S; Pschibul A; Süß P; Venhoff N; Runge K; Feige B; Denzel D; Nickel K; Schweizer T; Maier S; Egger K; Domschke K; Meyer PT; Prüss H; Tebartz van Elst L
    Front Psychiatry; 2020; 11():627. PubMed ID: 32848899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.
    Nersesjan V; Amiri M; Nilsson AC; Wamberg C; Jensen VVS; Petersen CB; Hejl AM; Lebech AM; Theut AM; Jørgensen CS; Blaabjerg M; Benros ME; Kondziella D
    Brain Commun; 2023; 5(5):fcad274. PubMed ID: 37908236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples.
    Pankratz B; von Zedtwitz K; Runge K; Denzel D; Nickel K; Schlump A; Pitsch K; Maier S; Dersch R; Voderholzer U; Domschke K; Tebartz van Elst L; Schiele MA; Prüss H; Endres D
    World J Biol Psychiatry; 2023 Apr; 24(4):292-302. PubMed ID: 35904379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.
    Bien CG; Rohleder C; Mueller JK; Bien CI; Koethe D; Leweke FM
    Front Psychiatry; 2021; 12():654602. PubMed ID: 33841216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies.
    Spezialetti R; Bluestein HG; Peter JB; Alexander EL
    Am J Med; 1993 Aug; 95(2):153-60. PubMed ID: 8356981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anti-cytoplasmic antibodies in cerebrospinal fluid and serum of patients with chronic severe mental disorders.
    Endres D; Pankratz B; Thiem S; Runge K; Schlump A; Feige B; Nickel K; Reisert M; Mast H; Urbach H; Schiele MA; Domschke K; Berger B; Venhoff N; Prüss H; Tebartz van Elst L
    World J Biol Psychiatry; 2022 Dec; 23(10):794-801. PubMed ID: 35168497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex difference in cerebrospinal fluid/blood albumin quotients in patients with schizophreniform and affective psychosis.
    Meixensberger S; Bechter K; Dersch R; Feige B; Maier S; Schiele MA; Runge K; Denzel D; Nickel K; Spieler D; Urbach H; Prüss H; Domschke K; Tebartz van Elst L; Endres D
    Fluids Barriers CNS; 2020 Nov; 17(1):67. PubMed ID: 33176794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of anti-neuronal antibodies in children with neurological disorders beyond encephalitis.
    Nikolaus M; Meisel C; Kreye J; Prüss H; Reindl M; Kaindl AM; Schuelke M; Knierim E
    Eur J Paediatr Neurol; 2020 Sep; 28():159-166. PubMed ID: 32807683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T; Hirata D; Onda K; Nara H; Minota S
    J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
    Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
    mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of cerebrospinal fluid autoantibodies in patients with seizures or epilepsies of unknown etiology.
    Schulz P; Lütt A; Stöcker W; Teegen B; Holtkamp M; Prüss H
    Front Neurol; 2023; 14():1211812. PubMed ID: 37475738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
    Franke C; Ferse C; Kreye J; Reincke SM; Sanchez-Sendin E; Rocco A; Steinbrenner M; Angermair S; Treskatsch S; Zickler D; Eckardt KU; Dersch R; Hosp J; Audebert HJ; Endres M; Ploner JC; Prüß H
    Brain Behav Immun; 2021 Mar; 93():415-419. PubMed ID: 33359380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Anti-neural Autoantibodies in a Psychiatric Patient Cohort-Paradigmatic Application of Criteria for Autoimmune-Based Psychiatric Syndromes.
    Hansen N; Juhl AL; Grenzer IM; Rentzsch K; Wiltfang J; Fitzner D
    Front Psychiatry; 2022; 13():864769. PubMed ID: 35711589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.